MSCI Inc. (NYSE:MSCI) shares reached a new 52-week high during mid-day trading on Thursday . The company traded as high as $444.04 and last traded at $443.59, with a volume of 2746 shares changing hands. The stock had previously closed at $436.99.
Several equities analysts have commented on MSCI shares. Morgan Stanley upped their price objective on MSCI from $384.00 to $391.00 and gave the company an “equal weight” rating in a research report on Wednesday, October 28th. Atlantic Securities lowered shares of MSCI from an “overweight” rating to a “neutral” rating in a report on Thursday, November 26th. Barclays upped their target price on shares of MSCI from $360.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, December 17th. Finally, Oppenheimer started coverage on shares of MSCI in a research note on Monday, October 5th. They set an “outperform” rating and a $416.00 price target for the company. Six equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $395.00.
The company has a market capitalization of $37.02 billion, a PE ratio of 66.75 and a beta of 0.90. The business’s 50-day simple moving average is $417.45 and its 200-day simple moving average is $373.71.
In other MSCI news, COO Cd Baer Pettit sold 2,500 shares of the business’s stock in a transaction on Friday, December 4th. The shares were sold at an average price of $424.17, for a total value of $1,060,425.00. Following the completion of the transaction, the chief operating officer now owns 270,859 shares in the company, valued at $114,890,262.03. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Scott A. Crum sold 1,000 shares of the business’s stock in a transaction on Tuesday, November 17th. The stock was sold at an average price of $395.00, for a total transaction of $395,000.00. Following the completion of the transaction, the insider now owns 28,279 shares of the company’s stock, valued at approximately $11,170,205. The disclosure for this sale can be found here. In the last 90 days, insiders sold 8,500 shares of company stock valued at $3,276,950. Insiders own 2.94% of the company’s stock.
Several institutional investors have recently added to or reduced their stakes in MSCI. Commonwealth Equity Services LLC lifted its position in shares of MSCI by 125.8% during the 2nd quarter. Commonwealth Equity Services LLC now owns 2,290 shares of the technology company’s stock worth $764,000 after purchasing an additional 1,276 shares during the last quarter. Blair William & Co. IL lifted its position in shares of MSCI by 32.8% during the 2nd quarter. Blair William & Co. IL now owns 1,366 shares of the technology company’s stock worth $456,000 after purchasing an additional 337 shares during the last quarter. Meiji Yasuda Asset Management Co Ltd. purchased a new stake in shares of MSCI during the 2nd quarter worth $387,000. Skandinaviska Enskilda Banken AB publ lifted its position in shares of MSCI by 16.1% during the 2nd quarter. Skandinaviska Enskilda Banken AB publ now owns 19,074 shares of the technology company’s stock worth $6,367,000 after purchasing an additional 2,644 shares during the last quarter. Finally, Horizon Investments LLC lifted its position in shares of MSCI by 387.1% during the 2nd quarter. Horizon Investments LLC now owns 4,598 shares of the technology company’s stock worth $1,535,000 after purchasing an additional 3,654 shares during the last quarter. 81.19% of the stock is owned by institutional investors and hedge funds.
About MSCI (NYSE:MSCI)
MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through four segments: Index, Analytics, ESG, and Real Estate. The Index segment primarily provides equity indexes for use in various areas of the investment process, including index-linked product creation and performance benchmarking, as well as portfolio construction and rebalancing, broker-dealer structured products, and asset allocation.
Further Reading: How to Invest in Growth Stocks
Receive News & Ratings for MSCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI and related companies with MarketBeat.com's FREE daily email newsletter.
